Auria
The first at-home biological breast cancer screening test for women.
Auria is the first at-home biological breast cancer screening test for women.
Powered by tears, Auria looks at protein biomarkers involved in the early inflammatory process due to abnormalities in breast tissue. Auria includes a clinical consultation with a breast health specialist to review results, discuss risk, and answer questions. Backed by physicians, clinical trials, and peer-reviewed publications, Auria’s convenient and non-invasive test empowers women on their breast health journey where early detection is the key in the fight against breast cancer.
Auria is available for women starting at age 30 and for any size, any shape, dense breasts, implants, all bodies, and all breasts.
Auria is a product of biotech startup Namida Lab, the world leader in developing accessible proteomic cancer screening tools.
